1. Academic Validation
  2. Advances in the discovery of exosome inhibitors in cancer

Advances in the discovery of exosome inhibitors in cancer

  • J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330. doi: 10.1080/14756366.2020.1754814.
Huarui Zhang 1 2 Jun Lu 1 3 2 Jin Liu 1 2 Ge Zhang 1 2 Aiping Lu 1 2
Affiliations

Affiliations

  • 1 Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases (TMBJ), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China.
  • 2 Institute of Integrated Bioinfomedicine and Translational Science, Hong Kong Baptist University Shenzhen Research Institute and Continuing Education, Shenzhen, China.
  • 3 School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Abstract

Exosomes are small membrane vesicles released by most eukaryotic cells. They are considered to play an essential role in cell-to-cell communication, and It is also found that they serve as functional mediators in many severe diseases, including progression of various types of cancers. Inhibition of exosome release may slow the progression of some cancers; thus, exosome has been an attractive target for Cancer treatment. Over the years, considerable efforts have been made to discover novel, highly potent and excellently selective exosome inhibitors. Most of these inhibitors are derived from synthetic compounds, some of which are currently existed drugs and found to have the potential to inhibit exosome release. In this review, we briefly discussed the development of exosome inhibitors that are currently discovered and provided guidance for the future development of inhibitors.

Keywords

Exosome; cancer; exosome inhibitors; extracellular vesicles.

Figures
Products